Table 1 Preoperative data.
From: Predictive scoring systems for mortality in heart transplant patients with liver cirrhosis
Variables | Survivors (n = 46) | Non-survivors (n = 20) | P-value |
|---|---|---|---|
Age, years | 40.94 ± 16.92 | 40.92 ± 18.21 | 0.80 |
Sex, Male | 18 (39.1) | 8 (40.0) | 0.62 |
Body mass index (kg/m2) | 21.75 ± 4.54 | 23.37 ± 5.96 | 0.29 |
Hypertension | 4 (8.7) | 4 (20.0) | 0.40 |
Diabetes mellitus | 6 (13.0) | 2 (10.0) | 0.49 |
Hyperlipidemia | 0 | 2 (10.0) | 0.27 |
Smoking history | 12 (26.1) | 2 (10.0) | 0.18 |
CKD | 5 (10.9) | 6 (30.0) | 0.12 |
Old CVA | 3 (6.5) | 2 (10.0) | 0.61 |
CAOD | 13 (28.3) | 4 (20.0) | 0.27 |
NYHA III-IV | 41 (89.1) | 16 (80.0) | 0.51 |
ECMO support | 5 (10.9) | 0 | 0.01 |
LVEF, % | 28.33 ± 16.86 | 29.39 ± 19.11 | 0.46 |
RVSP, mmHg | 49.60 ± 16.89 | 46.71 ± 8.96 | 0.18 |
Laboratory data | |||
Creatinine | 0.91 ± 0.30 | 1.77 ± 1.70 | < 0.01 |
Bilirubin | 1.65 ± 2.18 | 5.08 ± 9.77 | 0.01 |
Albumin | 3.54 ± 0.61 | 3.24 ± 0.71 | 0.87 |
AST | 69.86 ± 105.82 | 88.77 ± 106.43 | 0.61 |
ALT | 51.53 ± 83.51 | 117.46 ± 214.01 | 0.01 |
INR | 1.29 ± 0.48 | 1.36 ± 0.34 | 0.48 |
Diagnosis of heart failure | |||
Congenital heart disease | 6 (13.0) | 3 (15.0) | 0.43 |
Dilated cardiomyopathy | 28 (60.9) | 10 (50.0) | |
Ischemic cardiomyopathy | 6 (13.0) | 4 (20.0) | |
Valvular heart disease | 4 (8.7) | 3 (15.0) | |
Others | 2 (4.3) | 0 | |
Cause of liver cirrhosis | |||
Cardiac | 43 (93.5) | 19 (95.0) | 0.61 |
Hepatitis | 3 (6.5) | 0 (0) | |
Alcoholism | 0 (0) | 1 (5.0) | |
Liver stiffness measure (LSM) score, kPa | 14.82 ± 1.67 | 16.54 ± 1.61 | 0.114 |
Metavir classification | 0.077 | ||
4 | 46 (100) | 20 (100) | |
Risk assessment | |||
MELD score | 10.60 ± 4.20 | 16.39 ± 6.90 | 0.01 |
MELD-XI score | 11.76 ± 3.64 | 18.21 ± 9.34 | < 0.01 |
CTP score | 7.22 ± 1.36 | 12.23 ± 1.24 | 0.03 |
